Is a Potential Tumor Suppressor Gene Commonly Inactivated by Epigenetic Mechanisms in Colorectal Cancer

English version České info

NTRK3 is a member of the neurotrophin receptor family and regulates cell survival. It appears to be a dependence receptor, and thus has the potential to act as an oncogene or as a tumor suppressor gene. NTRK3 is a receptor for NT-3 and when bound to NT-3 it induces cell survival, but when NT-3 free, it induces apoptosis. We identified aberrantly methylated NTRK3 in colorectal cancers through a genome-wide screen for hypermethylated genes. This discovery led us to assess whether NTRK3 could be a tumor suppressor gene in the colon. NTRK3 is methylated in 60% of colon adenomas and 67% of colon adenocarcinomas. NTRK3 methylation suppresses NTRK3 expression. Reconstitution of NTRK3 induces apoptosis in colorectal cancers, if NT-3 is absent. Furthermore, the loss of NTRK3 expression associates with neoplastic transformation in vitro and in vivo. We also found that a naturally occurring mutant NTRK3 found in human colorectal cancer inhibits the tumor suppressor activity of NTRK3. In summary, our findings suggest NTRK3 is a conditional tumor suppressor gene that is commonly inactivated in colorectal cancer by both epigenetic and genetic mechanisms whose function in the pathogenesis of colorectal cancer depends on the expression status of its ligand, NT-3.

Vyšlo v časopise: Is a Potential Tumor Suppressor Gene Commonly Inactivated by Epigenetic Mechanisms in Colorectal Cancer. PLoS Genet 9(7): e32767. doi:10.1371/journal.pgen.1003552
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003552

Souhrn

Zdroje

1. GradyWM, CarethersJM (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135 : 1079–1099.

2. JonesPA, BaylinSB (2007) The epigenomics of cancer. Cell 128 : 683–692.

3. KazAM, WongCJ, LuoY, VirginJB, WashingtonMK, et al. (2011) DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses. Epigenetics 6 : 1403–1412.

4. JinW, KimGM, KimMS, LimMH, YunC, et al. (2010) TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis 31 : 1939–1947.

5. JinW, LeeJJ, KimMS, SonBH, ChoYK, et al. (2011) DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma. Biochem Biophys Res Commun 406 : 89–95.

6. Bouzas-RodriguezJ, CabreraJR, Delloye-BourgeoisC, IchimG, DelcrosJG, et al. (2010) Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 120 : 850–858.

7. LutherJA, BirrenSJ (2009) Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic properties. Auton Neurosci-Basic 151 : 46–60.

8. NakagawaraA (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169 : 107–114.

9. TognonC, KnezevichSR, HuntsmanD, RoskelleyCD, MelnykN, et al. (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2 : 367–376.

10. Tauszig-DelamasureS, YuLY, CabreraJR, Bouzas-RodriguezJ, Mermet-BouvierC, et al. (2007) The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci U S A 104 : 13361–13366.

11. NikoletopoulouV, LickertH, FradeJM, RencurelC, GiallonardoP, et al. (2010) Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467 : 59–63.

12. GoldschneiderD, MehlenP (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29 : 1865–1882.

13. XuX, TahanSR, PashaTL, ZhangPJ (2003) Expression of neurotrophin receptor Trk-C in nevi and melanomas. J Cutan Pathol 30 : 318–322.

14. SegalRA, GoumnerovaLC, KwonYK, StilesCD, PomeroySL (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci U S A 91 : 12867–12871.

15. BardelliA, ParsonsDW, SillimanN, PtakJ, SzaboS, et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300 : 949.

16. WoodLD, CalhounES, SillimanN, PtakJ, SzaboS, et al. (2006) Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat 27 : 1060–1061.

17. KaplanDR, MillerFD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10 : 381–391.

18. ReichardtLF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361 : 1545–1564.

19. KimMS, LeeJ, SidranskyD (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29 : 181–206.

20. IssaJP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4 : 988–993.

21. ThibertC, TeilletMA, LapointeF, MazelinL, Le DouarinNM, et al. (2003) Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science 301 : 843–846.

22. HuangEJ, ReichardtLF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72 : 609–642.

23. PorterAC, VaillancourtRR (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17 : 1343–1352.

24. FoehrED, LinX, O'MahonyA, GeleziunasR, BradshawRA, et al. (2000) NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci 20 : 7556–7563.

25. WootenMW, VandenplasML, SeibenhenerML, GeethaT, Diaz-MecoMT (2001) Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway. Mol Cell Biol 21 : 8414–8427.

26. KazAM, LuoY, DzieciatkowskiS, ChakA, WillisJE, et al. (2012) Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma. Genes Chromosomes Cancer 51 : 384–393.

27. LuoY, TsuchiyaKD, Il ParkD, FauselR, KanngurnS, et al. (2013) RET is a potential tumor suppressor gene in colorectal cancer. Oncogene 32 : 2037–2047.

28. GradyWM, RajputA, LutterbaughJD, MarkowitzSD (2001) Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 61 : 900–902.

29. WhiteheadRH, VaneedenPE, NobleMD, AtaliotisP, JatPS (1993) Establishment of Conditionally Immortalized Epithelial-Cell Lines from Both Colon and Small-Intestine of Adult H-2kb-Tsa58 Transgenic Mice (Vol 90, Pg 587, 1993). P Natl Acad Sci USA 90 : 6894–6894.

30. LuoYX, CuiJ, WangL, ChenDK, PengJS, et al. (2009) Identification of cancer-associated proteins by proteomics and downregulation of beta-tropomyosin expression in colorectal adenoma and cancer. Proteomics Clin Appl 3 : 1397–1406.